What is the recommended retesting schedule for sexually transmitted infections (STIs) after completing treatment?

Recommended STI Retesting Schedule After Treatment

For chlamydia and gonorrhea, retest all patients at 3 months after treatment to detect reinfection, and consider retesting whenever they return for care within 12 months regardless of partner treatment status.

Key Retesting Recommendations by Infection

Chlamydia and Gonorrhea

• Retest at 3 months post-treatment for all patients to detect reinfection 1, 2
• Women are highest priority due to elevated risk of PID and complications with repeat infections 2
• Retest at any visit within 3-12 months after treatment, regardless of whether partners were treated 2
• Men should also be retested at 3-6 months, particularly those with documented infections 1

Test-of-Cure vs. Rescreening: Critical Distinction

Test-of-cure is NOT recommended for patients treated with standard regimens (azithromycin or doxycycline) unless:

• Therapeutic compliance is questionable
• Symptoms persist
• Reinfection is suspected 2

Important caveat: Testing earlier than 3 weeks post-treatment can yield false-positive results from dead organisms or false-negatives from low organism counts 2

Special Populations

Pregnant Women:

• Test-of-cure IS required at 3 weeks after completing therapy 2, 3
• Use NAAT or culture for confirmation 2
• This is the major exception to the "no test-of-cure" rule due to maternal and neonatal sequelae risks

Adolescents:

• Particularly high priority for 3-month rescreening 3
• Research shows 25% acquire first STI within 1 year of first intercourse 4

Clinical Rationale

The evidence consistently shows that most post-treatment infections are reinfections, not treatment failures 2. Reinfection rates are substantial:

• 11-15% of women reinfected at 3-4 months 5
• 25.8% of women and 14.7% of men acquire new infections within 12 months 5
• Repeat infections carry higher risk for PID and complications than initial infections 2

Practical Implementation

At time of treatment:

• Instruct patients to abstain from sex for 7 days after single-dose therapy or until completion of 7-day regimen 2
• Schedule 3-month follow-up appointment before patient leaves
• Ensure all partners are treated within 60 days of symptom onset or diagnosis 2

Common pitfall: Many patients (approximately 50-75%) do not return for recommended retesting 6, 7, 8. Active outreach and automatic scheduling are essential but still yield suboptimal rates.

Proctitis-Specific Guidance

For acute proctitis from gonorrhea or chlamydia:

• Retest at 3 months for the specific pathogen 9
• Abstain from intercourse until completion of 7-day regimen and symptom resolution 9

Bottom Line Algorithm

1. All chlamydia/gonorrhea patients: Schedule 3-month retest at time of treatment
2. Women with chlamydia: Highest priority; retest at 3 months AND at any visit within 12 months
3. Pregnant women: Exception—perform test-of-cure at 3 weeks post-treatment
4. Symptomatic or non-compliant patients: Consider earlier evaluation, but wait ≥3 weeks for valid testing
5. All patients: Ensure partner treatment and sexual abstinence during treatment period